Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
50 Schweiger Dermatology Group Physicians Named 2022 Castle Connolly Top Doctors
-
Beeflow and Watts Solitary Bees Partner to Increase Biodiversity in Agriculture by introducing Blue Orchard Bees to California Almond Orchards
-
Caterer Compass feeds share price rise with strong revenue recovery
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497J BERNSTEIN SANFORD C FUND
-
Omicron depresses U.S. private payrolls in temporary setback to labor market
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K Bernstein Fund Inc
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K Bernstein Fund Inc
-
Form 497K Bernstein Fund Inc
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497 Bernstein Fund Inc
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497 BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
UPDATE: Bernstein Downgrades Clorox (CLX) to Underperform
-
UPDATE: Bernstein Downgrades Kimberly Clark (KMB) to Underperform
-
UPDATE: Bernstein Upgrades Colgate-Palmolive Company (CL) to Market Perform
-
iM Global Partner and Richard Bernstein Advisors launch new Responsible Global Allocation ETF
-
SVB Leerink LLC Announces Company Name Change to SVB Securities LLC
-
VOYAGER DIGITAL ANNOUNCES PARTICIPATION IN FEBRUARY INVESTOR EVENTS
-
SQZ Biotechnologies (SQZ) Reports Publication of Comprehensive Preclinical Research on SQZ APC’s Ability to Overcome Fundamental Biological Barrier to Effective and Efficient Killer T Cell Activatio
-
SQZ Biotechnologies Announces Publication of Comprehensive Preclinical Research on SQZ® APC’s Ability to Overcome Fundamental Biological Barrier to Effective and Efficient Killer T Cell Activation
-
ESG Investing Announces Award Winners
-
Form 4 XpresSpa Group, Inc. For: Jan 26 Filed by: Bernstein Bruce
-
Form 485BPOS Bernstein Fund Inc
-
Form 485BPOS BERNSTEIN SANFORD C FUND
-
Ryan Shazier Fund for Spinal Rehabilitation Welcomes 4 New Board Members for 2022
-
Form 485BPOS BERNSTEIN SANFORD C FUND
-
Form 485BPOS Bernstein Fund Inc
-
Form 485BPOS BERNSTEIN SANFORD C FUND
-
De La Rue activist investor calls for sale or break-up of banknote printer - FT
-
AB to Report Fourth Quarter 2021 Results on February 11, 2022
-
Caterpillar sales soar, warns of margin pressure
-
NIHPLOD Officially Launches Customized Service N7 Plus
-
Balto Recognized As 2022 Best Place to Work By Purpose Jobs

